Application Advances of Carbon Nanoparticles in Thyroid Carcinoma Surgery_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 CHUNLin , HUANGMan ,  SUXin-liang , WUKai-nan

Department of Endocrinology and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China;

Corresponding?author：

SUXin-liang, Email: suxinliang@21cn.com

Keywords：

Carbon nanoparticle; Lymphatic mapping; Thyroid carcinoma; Parathyroid gland

DOI：

10.7507/1007-9424.20140156

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the value of carbon nanoparticles on surgery for thyroid carcinoma. Method Literatures about application of carbon nanoparticles and lymphatic mapping in the thyroid carcinoma were reviewed. Results The carbon nanoparticle was a new lymph tracer with a clear lymphatic mapping and a longer time for dying, which could accurately reflect the status of cervical lymph nodes, trace the sentinel lymph node in the thyroid carcinoma. The parathyroid gland could not be stained black, it was easy to be identified and protected. Conclusions The carbon nanoparticle provides an effective help in treatment for thyroid carcinoma. The more extensive and more profound application of lymphatic mapping depends on more clinical study.

Citation： CHUNLin, HUANGMan, SUXin-liang, WUKai-nan. Application Advances of Carbon Nanoparticles in Thyroid Carcinoma Surgery. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2014, 21(5): 646-649. doi: 10.7507/1007-9424.20140156 Copy

1.	姚京, 劉洋, 田文.分化型甲狀腺癌再次手術技巧的探討[J].中國普外基礎與臨床雜志, 2013, 20(9):981-986.
2.	Davidson HC, Park BJ, Johnson JT.Papillary thyroid cancer:controversies in the management of neck metastasis[J].Laryngoscope, 2008, 118(12):2161-2165.
3.	曾玉劍, 錢軍, 程若川, 等.甲狀腺癌術中淋巴示蹤劑應用對于甲狀旁腺保護作用的研究[J].重慶醫學, 2012, 41(11):1076, 1088.
4.	Weinberg J, Greaney EM.Identification of regional lymph nodes by means of a vital staining dye during surgery of gastric cancer[J].Surg Gynecol Obstet, 1950, 90(5):561-567.
5.	Morl F.Importance of the sternal lymph vessels for metastases of cancer of the breast[J].Chirurg, 1952, 23(7):298-300.
6.	Reitsamer R, Peintinger F, Prokop E, et al.Sentinel lymph node biopsy alone without axillary lymph node dissection-follow up of sentinel lymph node negative breast cancer patients[J].Eur J Surg Oncol, 2003, 29(3):221-223.
7.	邱樹升, 李良, 李新兵, 等.美藍法定位前哨淋巴結活檢在cN0分化型甲狀腺癌治療中的應用[J].中國腫瘤外科雜志, 2012, 4(4):242-244.
8.	蘇力夫, 張生彬, 朱永蒙.納米碳示蹤前哨淋巴結在cN0甲狀腺乳頭狀癌中的應用[J].中國現代醫學雜志, 2013, 23(7):110-112.
9.	尹源, 汪曉東, 呂東昊, 等.淋巴示蹤劑在結直腸癌外科的研究進展[J].中國普外基礎與臨床雜志, 2010, 17(3):306-308.
10.	徐鯤, 劉曉安, 王水, 等.乳腺癌前哨淋巴結活檢染料選擇的實驗研究[J].南京醫科大學學報:自然科學版, 2005, 25(3):201-203.
11.	Haigh PI, Giuliano AE.Sentinel lymph node dissection for thyroid malignancy[J].Recent Results Cancer Res, 2000, 157:201-205.
12.	Yang F, Jin C, Yang D, et al.Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment[J].Eur J Cancer, 2011, 47(12):1873-1882.
13.	蔡長茂, 李威.納米炭在普外科惡性腫瘤診治中的應用[J].中華實用診斷與治療雜志, 2010, 24(9):833-834.
14.	Montgomery LL, Thorne AC, Van Zee KJ, et al.Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer[J].Anesth Analg, 2002, 95(2):385-388.
15.	Dionigi G, Bacuzzi A, Bertocchi V, et al.Prospectives and surgical usefulness of perioperative parathyroid hormone assay in thyroid surgery[J].Expert Rev Med Devices, 2008, 5(6):699-704.
16.	傅朝春, 徐安書, 張杰, 等.甲狀腺手術中預防甲狀旁腺損傷的體會[J].中國普外基礎與臨床雜志, 2013, 19(3):333-334.
17.	朱精強.分化型甲狀腺癌頸淋巴結清掃的相關問題[J].中國普外基礎與臨床雜志, 2013, 19(8):809-813.
18.	閆利英, 李隨勤, 張少強, 等.甲狀腺全切及近全切術中甲狀旁腺的原位保護[J].臨床耳鼻咽喉科雜志, 2006, 20(21):980-982.
19.	黃韜.甲狀腺術中損傷的預防和處理[J].中國實用外科雜志, 2008, 28(3):179-180.
20.	趙挺, 顏育祥, 許踐剛, 等.975例甲狀腺疾病患者手術預防甲狀旁腺損傷體會[J].中國腫瘤, 2007, 16(6):467-468.
21.	Kihara M, Miyauchi A, Kontani K, et al.Recovery of parathyroid function after total thyroidectomy:long-term follow-up study[J].ANZ J Surg, 2005, 75(7):532-536.
22.	Derom AF, Wallaert PC, Janzing HM, et al.Intraoperative identification of parathyroid glands with methylene blue infusion[J].Am J Surg, 1993, 165(3):380-382.
23.	車紅纓, 曾玉劍, 程中.納米炭淋巴示蹤劑在胃癌淋巴結清掃和病理檢查中的價值[J].重慶醫學, 2009, 38(20):2571-2572.
24.	楊曉暉, 王勇, 王平.納米碳在腔鏡甲狀腺癌手術中的應用[J].腹腔鏡外科雜志, 2013, 18(4):262-265.
25.	楊志芳, 岳瑞雪, 朱智, 等.納米碳在cN0期甲狀腺乳頭狀癌中央區淋巴結清掃手術中的應用[J].中國普外基礎與臨床雜志, 2013, 20(9):976-980.
26.	張筱驊, 郝儒田, 尤捷, 等.甲狀腺淋巴管造影在鑒別甲狀旁腺中的意義[J].溫州醫學院學報, 2010, 40(1):31, 35.
27.	朱精強, 汪洵理, 魏濤, 等.納米碳甲狀旁腺負顯影辨認保護技術在甲狀腺癌手術中的應用[J].中國普外基礎與臨床雜志, 2013, 20(9):992-994.
28.	Lo CY, Lam KY.Routine parathyroid autotransplantation during thyroidectomy[J].Surgery, 2001, 129(3):318-323.
29.	Krag DN, Weaver DL.Pathological and molecular assessment of sentinel lymph nodes in solid tumors[J].Semin Oncol, 2002, 29(3):274-279.
30.	高慶軍, 王南鵬, 周彥, 等.甲狀腺乳頭狀癌頸部淋巴結轉移規律及影響因素分析[J].中國普外基礎與臨床雜志, 2013, 20(3):303-309.
31.	賞金標, 王可敬.甲狀腺乳頭狀腺癌的前哨淋巴結研究[J].國際耳鼻咽喉頭頸外科雜志, 2006, 30(1):33-34, 48.
32.	Cabanas RM.An approach for the treatment of penile carcinoma[J].Cancer, 1977, 39(2):456-466.
33.	Morton DL, Wen DR, Wong JH, et al.Technical details of intraoperative lymphatic mapping for early stage melanoma[J].Arch Surg, 1992, 127(4):392-399.
34.	Besli? N.The role of sentinel lymph node detection in management of patients with breast cancer[J].Med Arh, 2008, 62(4):240-241.
35.	Kelemen PR, Van Herle AJ, Giuliano AE.Sentinel lymphadenectomy in thyroid malignant neoplasms[J].Arch Surg, 1998, 133(3):288-292.
36.	Lee SK, Choi JH, Lim HI, et al.Sentinel lymph node biopsy in papillary thyroid cancer:comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer[J].Eur J Surg Oncol, 2009, 35(9):974-979.
37.	Liu CL, Yang TL, Chen BF.Sentinel lymph node mapping with emulsion of activated carbon particles in patients with pre-mastectomy diagnosis of intraductal carcinoma of the breast[J].J Chin Med Assoc, 2003, 66(7):406-410.
38.	Catarci M, Guadagni S, Zaraca F, et al.Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer[J].Ann Surg Oncol, 1999, 5(7):580-584.
39.	王曉雷, 吳躍煌, 徐震綱, 等.納米碳在鑒別甲狀腺周圍淋巴結和甲狀旁腺中的作用[J].中華耳鼻咽喉頭頸外科雜志, 2009, 44(2):136-140.
40.	江國斌, 方紅燕, 蔡建明.納米碳混懸液示蹤前哨淋巴結在甲狀腺乳頭狀癌中的應用[J].中國癌癥雜志, 2010, 20(12):938-940.
41.	Fukui Y, Yamakawa T, Taniki T, et al.Sentinel lymph node biopsy in patients with papillary thyroid carcinoma[J].Cancer, 2001, 92(11):2868-2874.
42.	Hao RT, Chen J, Zhao LH, et al.Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma[J].Eur J Surg Oncol, 2012, 38(8):718-724.
43.	江國斌, 賈中明, 劉艷, 等.納米炭定位前哨淋巴結在cN0甲狀腺乳頭狀癌中的臨床研究[J].臨床合理用藥, 2013, 4(9C):9-11.

1. 姚京, 劉洋, 田文.分化型甲狀腺癌再次手術技巧的探討[J].中國普外基礎與臨床雜志, 2013, 20(9):981-986.
2. Davidson HC, Park BJ, Johnson JT.Papillary thyroid cancer:controversies in the management of neck metastasis[J].Laryngoscope, 2008, 118(12):2161-2165.
3. 曾玉劍, 錢軍, 程若川, 等.甲狀腺癌術中淋巴示蹤劑應用對于甲狀旁腺保護作用的研究[J].重慶醫學, 2012, 41(11):1076, 1088.
4. Weinberg J, Greaney EM.Identification of regional lymph nodes by means of a vital staining dye during surgery of gastric cancer[J].Surg Gynecol Obstet, 1950, 90(5):561-567.
5. Morl F.Importance of the sternal lymph vessels for metastases of cancer of the breast[J].Chirurg, 1952, 23(7):298-300.
6. Reitsamer R, Peintinger F, Prokop E, et al.Sentinel lymph node biopsy alone without axillary lymph node dissection-follow up of sentinel lymph node negative breast cancer patients[J].Eur J Surg Oncol, 2003, 29(3):221-223.
7. 邱樹升, 李良, 李新兵, 等.美藍法定位前哨淋巴結活檢在cN0分化型甲狀腺癌治療中的應用[J].中國腫瘤外科雜志, 2012, 4(4):242-244.
8. 蘇力夫, 張生彬, 朱永蒙.納米碳示蹤前哨淋巴結在cN0甲狀腺乳頭狀癌中的應用[J].中國現代醫學雜志, 2013, 23(7):110-112.
9. 尹源, 汪曉東, 呂東昊, 等.淋巴示蹤劑在結直腸癌外科的研究進展[J].中國普外基礎與臨床雜志, 2010, 17(3):306-308.
10. 徐鯤, 劉曉安, 王水, 等.乳腺癌前哨淋巴結活檢染料選擇的實驗研究[J].南京醫科大學學報:自然科學版, 2005, 25(3):201-203.
11. Haigh PI, Giuliano AE.Sentinel lymph node dissection for thyroid malignancy[J].Recent Results Cancer Res, 2000, 157:201-205.
12. Yang F, Jin C, Yang D, et al.Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment[J].Eur J Cancer, 2011, 47(12):1873-1882.
13. 蔡長茂, 李威.納米炭在普外科惡性腫瘤診治中的應用[J].中華實用診斷與治療雜志, 2010, 24(9):833-834.
14. Montgomery LL, Thorne AC, Van Zee KJ, et al.Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer[J].Anesth Analg, 2002, 95(2):385-388.
15. Dionigi G, Bacuzzi A, Bertocchi V, et al.Prospectives and surgical usefulness of perioperative parathyroid hormone assay in thyroid surgery[J].Expert Rev Med Devices, 2008, 5(6):699-704.
16. 傅朝春, 徐安書, 張杰, 等.甲狀腺手術中預防甲狀旁腺損傷的體會[J].中國普外基礎與臨床雜志, 2013, 19(3):333-334.
17. 朱精強.分化型甲狀腺癌頸淋巴結清掃的相關問題[J].中國普外基礎與臨床雜志, 2013, 19(8):809-813.
18. 閆利英, 李隨勤, 張少強, 等.甲狀腺全切及近全切術中甲狀旁腺的原位保護[J].臨床耳鼻咽喉科雜志, 2006, 20(21):980-982.
19. 黃韜.甲狀腺術中損傷的預防和處理[J].中國實用外科雜志, 2008, 28(3):179-180.
20. 趙挺, 顏育祥, 許踐剛, 等.975例甲狀腺疾病患者手術預防甲狀旁腺損傷體會[J].中國腫瘤, 2007, 16(6):467-468.
21. Kihara M, Miyauchi A, Kontani K, et al.Recovery of parathyroid function after total thyroidectomy:long-term follow-up study[J].ANZ J Surg, 2005, 75(7):532-536.
22. Derom AF, Wallaert PC, Janzing HM, et al.Intraoperative identification of parathyroid glands with methylene blue infusion[J].Am J Surg, 1993, 165(3):380-382.
23. 車紅纓, 曾玉劍, 程中.納米炭淋巴示蹤劑在胃癌淋巴結清掃和病理檢查中的價值[J].重慶醫學, 2009, 38(20):2571-2572.
24. 楊曉暉, 王勇, 王平.納米碳在腔鏡甲狀腺癌手術中的應用[J].腹腔鏡外科雜志, 2013, 18(4):262-265.
25. 楊志芳, 岳瑞雪, 朱智, 等.納米碳在cN0期甲狀腺乳頭狀癌中央區淋巴結清掃手術中的應用[J].中國普外基礎與臨床雜志, 2013, 20(9):976-980.
26. 張筱驊, 郝儒田, 尤捷, 等.甲狀腺淋巴管造影在鑒別甲狀旁腺中的意義[J].溫州醫學院學報, 2010, 40(1):31, 35.
27. 朱精強, 汪洵理, 魏濤, 等.納米碳甲狀旁腺負顯影辨認保護技術在甲狀腺癌手術中的應用[J].中國普外基礎與臨床雜志, 2013, 20(9):992-994.
28. Lo CY, Lam KY.Routine parathyroid autotransplantation during thyroidectomy[J].Surgery, 2001, 129(3):318-323.
29. Krag DN, Weaver DL.Pathological and molecular assessment of sentinel lymph nodes in solid tumors[J].Semin Oncol, 2002, 29(3):274-279.
30. 高慶軍, 王南鵬, 周彥, 等.甲狀腺乳頭狀癌頸部淋巴結轉移規律及影響因素分析[J].中國普外基礎與臨床雜志, 2013, 20(3):303-309.
31. 賞金標, 王可敬.甲狀腺乳頭狀腺癌的前哨淋巴結研究[J].國際耳鼻咽喉頭頸外科雜志, 2006, 30(1):33-34, 48.
32. Cabanas RM.An approach for the treatment of penile carcinoma[J].Cancer, 1977, 39(2):456-466.
33. Morton DL, Wen DR, Wong JH, et al.Technical details of intraoperative lymphatic mapping for early stage melanoma[J].Arch Surg, 1992, 127(4):392-399.
34. Besli? N.The role of sentinel lymph node detection in management of patients with breast cancer[J].Med Arh, 2008, 62(4):240-241.
35. Kelemen PR, Van Herle AJ, Giuliano AE.Sentinel lymphadenectomy in thyroid malignant neoplasms[J].Arch Surg, 1998, 133(3):288-292.
36. Lee SK, Choi JH, Lim HI, et al.Sentinel lymph node biopsy in papillary thyroid cancer:comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer[J].Eur J Surg Oncol, 2009, 35(9):974-979.
37. Liu CL, Yang TL, Chen BF.Sentinel lymph node mapping with emulsion of activated carbon particles in patients with pre-mastectomy diagnosis of intraductal carcinoma of the breast[J].J Chin Med Assoc, 2003, 66(7):406-410.
38. Catarci M, Guadagni S, Zaraca F, et al.Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer[J].Ann Surg Oncol, 1999, 5(7):580-584.
39. 王曉雷, 吳躍煌, 徐震綱, 等.納米碳在鑒別甲狀腺周圍淋巴結和甲狀旁腺中的作用[J].中華耳鼻咽喉頭頸外科雜志, 2009, 44(2):136-140.
40. 江國斌, 方紅燕, 蔡建明.納米碳混懸液示蹤前哨淋巴結在甲狀腺乳頭狀癌中的應用[J].中國癌癥雜志, 2010, 20(12):938-940.
41. Fukui Y, Yamakawa T, Taniki T, et al.Sentinel lymph node biopsy in patients with papillary thyroid carcinoma[J].Cancer, 2001, 92(11):2868-2874.
42. Hao RT, Chen J, Zhao LH, et al.Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma[J].Eur J Surg Oncol, 2012, 38(8):718-724.
43. 江國斌, 賈中明, 劉艷, 等.納米炭定位前哨淋巴結在cN0甲狀腺乳頭狀癌中的臨床研究[J].臨床合理用藥, 2013, 4(9C):9-11.

Previous Article
Complete Mechanical Cervical Side-to-side Esophago-gastric Tube Anastomosis in 60 Patients
Next Article
胸部鈍挫傷所致三尖瓣重度反流一例

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Application Advances of Carbon Nanoparticles in Thyroid Carcinoma Surgery

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content